A clotting factor replacement for haemophilia A
Factor VIII
A clotting factor given by injection into a vein to treat and prevent bleeding in haemophilia A.
What is Factor VIII?
Factor VIII is a specialist medicine that replaces a clotting protein people with haemophilia A are missing, so their blood can clot properly. It is given by injection into a vein, either to stop a bleed or regularly to prevent bleeding. Some people develop antibodies (called inhibitors) that stop it working, and there is a small risk of clots. Some products are made from donated human plasma, which carries a very small risk linked to blood products, while recombinant (laboratory-made) products avoid that risk. It is used under the care of a specialist haemophilia team.
Education and reference only. This is a plain-language guide to Factor VIII — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.
What it is
Factor VIII is a clotting protein that the blood needs to form a proper clot. People with haemophilia A are born missing or low in this protein, so they bleed for longer and can bleed into joints and muscles. Factor VIII medicine replaces the missing protein, restoring the blood's ability to clot. It is given as an injection into a vein, either to treat a bleed when it happens or regularly to prevent bleeds. Some products are made from donated human plasma, while others are recombinant, meaning they are made in the laboratory without using human plasma. It is used under the care of a specialist haemophilia centre.
How it works
Blood clotting depends on a chain of proteins working together; factor VIII is one of these. In haemophilia A, this protein is missing or too low, so the clotting chain is broken and bleeding does not stop properly. The medicine supplies factor VIII directly into the bloodstream, filling the gap in the chain so clots can form normally again. Because the protein is gradually used up and cleared, it is given as repeated injections, either at the time of a bleed or on a regular schedule to keep enough in the blood to prevent bleeds before they start.
Company & origin
Originated / developed by: Specialist manufacturers.
A specialist medicine used in the UK to treat and prevent bleeding in haemophilia A, replacing the missing clotting protein by injection into a vein.
Practical use
How to take Factor VIII
General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.
- It is given by injection into a vein, either to treat a bleed or regularly to prevent bleeds, as your haemophilia team advises.
- Many people or their families are trained to give it at home so bleeds can be treated quickly.
- Treat a bleed as early as possible, as earlier treatment usually works better and protects the joints.
- Tell your team if it seems to be working less well, as this can be a sign of inhibitors developing.
- Keep in close contact with your haemophilia centre and carry information about your condition.
Weighing it up
Advantages & disadvantages of Factor VIII
Advantages
- Replaces the missing clotting protein so blood can clot, treating and preventing bleeds in haemophilia A.
- Can be given at home by trained patients or families, allowing quick treatment of bleeds.
- Recombinant (laboratory-made) products avoid the small risk linked to human plasma products.
Disadvantages
- Some people develop antibodies (inhibitors) that stop the factor working, a particular concern with factor VIII.
- There is a small risk of unwanted clots in some situations.
- Plasma-derived products carry a very small theoretical risk linked to blood products.
Practical use
Good to know
The key idea is simple: factor VIII replaces the clotting protein that is missing in haemophilia A, so it is a replacement treatment rather than a cure. Two important points are that some people develop antibodies, called inhibitors, that stop the factor working, which is a particular concern with factor VIII and one the team checks for, and that there is a small risk of unwanted clots in some situations. Where the product comes from matters too: plasma-derived products are made from donated human blood and carry a very small theoretical risk linked to blood products, whereas recombinant products are made in the laboratory and avoid that risk; your team will discuss which is right for you. Many people, or their families, are trained to give the injections at home, which makes treating bleeds quickly much easier. Carrying information about your condition and keeping in close contact with your haemophilia centre are important parts of staying safe.
Who should not take it / use with caution
- People who have had a serious allergic reaction to a factor VIII product should not use that product.
- It is used with extra care in people who have developed inhibitors or who are at higher risk of clots, under specialist guidance.
- It should only be used under the care of a specialist haemophilia centre.
Monitoring
- Checking for inhibitors (antibodies) that can stop the factor working.
- Reviewing how well bleeds are controlled and adjusting treatment as needed.
- Watching for allergic reactions and, where relevant, signs of clots.
Side effects
- Allergic-type reactions, which can range from mild to, rarely, serious.
- Development of inhibitors (antibodies) that make the treatment work less well.
- Reactions where the injection is given, and, uncommonly, unwanted clots.
Key interactions
- There are few routine medicine interactions, but tell your team about all your medicines.
- Medicines that affect clotting are reviewed by the team, as they may change bleeding or clotting risk.
- Switching between products is done under specialist guidance, with monitoring for inhibitors.
Available as: A powder made up into a solution for injection into a vein.
Answers
Factor VIII: frequently asked questions
What is factor VIII used for?
It treats and prevents bleeding in haemophilia A by replacing factor VIII, a clotting protein that people with the condition are missing or low in.
What are inhibitors?
Inhibitors are antibodies the body can make against the factor, which stop it working as well; this is a particular concern with factor VIII, so the team checks for them.
What is the difference between plasma-derived and recombinant factor VIII?
Plasma-derived products are made from donated human blood and carry a very small theoretical risk linked to blood products, while recombinant products are laboratory-made and avoid that risk.
Can I give it at home?
Yes, many people or their families are trained by the haemophilia team to give it at home, so bleeds can be treated quickly.
Does it cure haemophilia A?
No. It replaces the missing clotting protein to treat and prevent bleeds, but it does not cure the underlying condition.
Authoritative sources
- BNF
- NICE CKS
Building a medicines information resource?
We create evidence-led, dose-free drug and formulary references for teams.